Orion Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$945K	Sell	2,855 -112	-4%	-$38.1K	0.33%	51
2025 Q4	$1.18M	Sell	2,967 -173	-6%	-$76.6K	0.4%	42
2025 Q3	$1.43M	Sell	3,140 -100	-3%	-$40.7K	0.5%	36
2025 Q2	$1.06M	Sell	3,240 -100	-3%	-$27.7K	0.4%	45
2025 Q1	$902K	Hold	3,340	–	–	0.38%	47
2024 Q4	$786K	Sell	3,340 -85	-2%	-$22.4K	0.35%	53
2024 Q3	$942K	Sell	3,425 -150	-4%	-$39.1K	0.46%	44
2024 Q2	$869K	Sell	3,575 -100	-3%	-$15.8K	0.46%	41
2024 Q1	$549K	Hold	3,675	–	–	0.29%	65
2023 Q4	$703K	Hold	3,675	–	–	0.41%	50
2023 Q3	$651K	Sell	3,675 -300	-8%	-$57.2K	0.42%	48
2023 Q2	$755K	Hold	3,975	–	–	0.5%	47
2023 Q1	$796K	Sell	3,975 -30	-0.7%	-$6.31K	0.53%	40
2022 Q4	$952K	Sell	4,005 -170	-4%	-$36.3K	0.7%	32
2022 Q3	$836K	Sell	4,175 -1,690	-29%	-$322K	0.67%	36
2022 Q2	$855K	Sell	5,865 -700	-11%	-$99.3K	0.67%	37
2022 Q1	$1.07M	Sell	6,565 -100	-2%	-$15.2K	0.65%	37
2021 Q4	$1.13M	Sell	6,665 -10	-0.1%	-$1.86K	0.64%	38
2021 Q3	$1.26M	Hold	6,675	–	–	0.76%	35
2021 Q2	$1.13M	Hold	6,675	–	–	0.7%	38
2021 Q1	$942K	Hold	6,675	–	–	0.66%	43
2020 Q4	$868K	Buy	+6,675	New	+$891K	0.64%	42